EUCTR2018-004891-36-ES进行中（未招募）1 期
Efficacy and Safety of Concizumab prophylaxis in patients with haemophilia A or B without inhibitors - explorer8
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •- Informed consent obtained before any trial-related activities. Trial-related activities are any procedures that are carried out as part of the trial, including activities to determine suitability for the trial
- •- Male aged 12 years or older at the time of signing informed consent.
- •- Congenital severe haemophilia A (FVIII less than 1%) or B (FIX 2% or less)
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 35
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 105
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •- Known or suspected hypersensitivity to monoclonal antibodies
- •- Known inherited or acquired coagulation disorder other than congenital haemophilia
- •- Presence of confirmed inhibitors 0.6 BU or greater at screening
研究者
相似试验
进行中（未招募）
1 期
Research study to look at how well the drug concizumab works in your body if you have haemophilia without inhibitorsHaemophilia AHaemophilia BMedDRA version: 20.0Level: LLTClassification code 10018938Term: Haemophilia A (Factor VIII)System Organ Class: 100000004850MedDRA version: 20.0Level: LLTClassification code 10018939Term: Haemophilia B (Factor IX)System Organ Class: 100000004850EUCTR2018-004891-36-HUovo Nordisk A/S158
进行中（未招募）
1 期
Research study to look at how well the drug concizumab works in your body if you have haemophilia with inhibitorsHaemophilia A with inhibitorsHaemophilia B with inhibitorsMedDRA version: 20.0Level: LLTClassification code 10053751Term: Hemophilia A with anti factor VIIISystem Organ Class: 100000004850MedDRA version: 20.0Level: LLTClassification code 10053752Term: Hemophilia B with anti factor IXSystem Organ Class: 100000004850EUCTR2018-004889-34-HRovo Nordisk A/S136
进行中（未招募）
1 期
Research study to look at how well the drug concizumab works in your body if you have haemophilia without inhibitorsHaemophilia AHaemophilia BMedDRA version: 20.0Level: LLTClassification code 10018938Term: Haemophilia A (Factor VIII)System Organ Class: 100000004850MedDRA version: 20.0Level: LLTClassification code 10018939Term: Haemophilia B (Factor IX)System Organ Class: 100000004850EUCTR2018-004891-36-DEovo Nordisk A/S158
进行中（未招募）
1 期
Research study to look at how well the drug concizumab works in your body if you have haemophilia with inhibitorsHaemophilia A with inhibitorsHaemophilia B with inhibitorsMedDRA version: 20.0Level: LLTClassification code 10053751Term: Hemophilia A with anti factor VIIISystem Organ Class: 100000004850MedDRA version: 20.0Level: LLTClassification code 10053752Term: Hemophilia B with anti factor IXSystem Organ Class: 100000004850EUCTR2018-004889-34-PTovo Nordisk A/S136
进行中（未招募）
1 期
Research study to look at how well the drug concizumab works in your body if you have haemophilia without inhibitorsHaemophilia AHaemophilia BMedDRA version: 20.0Level: LLTClassification code 10018938Term: Haemophilia A (Factor VIII)System Organ Class: 100000004850MedDRA version: 20.0Level: LLTClassification code 10018939Term: Haemophilia B (Factor IX)System Organ Class: 100000004850EUCTR2018-004891-36-FRovo Nordisk A/S150